Jiang, Yini <br/><br/>
Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway.  [electronic resource] 

 -  Experimental biology and medicine (Maywood, N.J.)  Mar 2014 
 - 347-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-3699 
<br/><br/><label>Standard No.: </label>10.1177/1535370213519215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipogenesis<br/>Adipose Tissue--metabolism<br/>Adrenal Cortex Hormones--adverse effects<br/>Animals<br/>Core Binding Factor Alpha 1 Subunit--genetics<br/>Disease Models, Animal<br/>Femur Head--drug effects<br/>Femur Head Necrosis--chemically induced<br/>Fibrinolysis--physiology<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hyperlipidemias--blood<br/>Lipids--blood<br/>Low Density Lipoprotein Receptor-Related Protein-5--genetics<br/>Male<br/>Methylprednisolone<br/>Neovascularization, Physiologic--drug effects<br/>Osteogenesis--drug effects<br/>Osteonecrosis--chemically induced<br/>PPAR gamma--antagonists & inhibitors<br/>Pravastatin--therapeutic use<br/>Rats<br/>Rats, Wistar<br/>Wnt Signaling Pathway--drug effects<br/>Wnt3A Protein--genetics<br/>beta Catenin--genetics